Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Sep;11(9):2164-71.
doi: 10.1111/jsm.12613. Epub 2014 Jun 12.

Hydroxyl fasudil, an inhibitor of Rho signaling, improves erectile function in diabetic rats: a role for neuronal ROCK

Sena F Sezen  1 , Gwen Lagoda, Biljana Musicki, Arthur L Burnett
Affiliations

Hydroxyl fasudil, an inhibitor of Rho signaling, improves erectile function in diabetic rats: a role for neuronal ROCK

Sena F Sezen et al. J Sex Med. 2014 Sep.

Abstract

Introduction: The pathogenesis of diabetic erectile dysfunction (ED) includes neuropathy, but the molecular basis for neurogenic ED is incompletely understood. The RhoA/ROCK pathway has been implicated in diabetic neuropathy and in ED, but its role in diabetic neurogenic ED is not known.

Aims: The aim of this study was to determine whether hydroxyl fasudil, a ROCK inhibitor, affects diabetic neuropathy-related ED.

Methods: Type 1 diabetes mellitus was induced in male rats by streptozotocin (75 mg/kg, intraperitoneally). After 8 weeks, diabetic rats were administered hydroxyl fasudil, a selective ROCK inhibitor (10 mg/kg/day, intraperitoneally) or vehicle, for 4 weeks. Age-matched control, nondiabetic, rats were treated intraperitoneally for 4 weeks with saline. At week 12, after a 2 day washout, neuro-stimulated erectile function was evaluated. Major pelvic ganglia (MPG) were collected for Western blot analysis of RhoA, ROCK-1, ROCK-2, phospho (P)-AKT (Ser(473) ), and P-phosphatase and tensin homolog (P-PTEN) (Ser(380) /Thr(382/383) ).

Main outcome measures: Effect of ROCK inhibitor hydroxyl fasudil on erectile function and ROCK/P-AKT/P-PTEN pathway in the MPG of diabetic rats.

Results: Erectile response was significantly (P < 0.05) reduced in diabetic rats compared with nondiabetic rats and was preserved (P < 0.05) in diabetic rats treated with hydroxyl fasudil. In diabetic rats, RhoA and ROCK-2 protein expressions in MPG were increased (P < 0.05) and remained increased in hydroxyl fasudil-treated rats. P-AKT (Ser(473) ) expression was decreased (P < 0.05), whereas P-PTEN (Ser(380) /Thr(382/383) ) expression was increased (P < 0.05) in MPG of diabetic rats compared with nondiabetic rats, and both were reversed (P < 0.05) in diabetic rats treated with hydroxyl fasudil.

Conclusion: Improved erectile function and restored P-AKT and P-PTEN in the MPG with hydroxyl fasudil treatment suggest the role of Rho signaling via PTEN/AKT pathway in neurogenic diabetic ED.

Keywords: Apoptosis; Diabetic Neuropathy; Major Pelvic Ganglia; P-AKT; P-PTEN.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: None

Figures

Figure 1
Figure 1
Effect of diabetes and hydroxyl fasudil on penile erection. Erectile response to electrical stimulation of the cavernous nerve is indicated by maximal ICP/MAP corrected for baseline (A) and total ICP/MAP corrected for baseline (B) in nondiabetic rats, diabetic rats, and diabetic rats treated with hydroxyl fasudil (10 mg/kg/day). Each bar represents the mean ± SEM of 6-8 rats. *P<0.05 vs nondiabetic, #P<0.05 vs diabetic. NonDiab = nondiabetic; Diab = diabetic; Diab + HF = diabetic treated with hydroxyl fasudil; AU = arbitrary units
Figure 2
Figure 2
Effect of diabetes and hydroxyl fasudil on RhoA (A), ROCK-2 (B), and ROCK-1 (C) protein expressions in the MPG. Upper panels are representative Western immunoblots of RhoA, ROCK-2, ROCK-1, and β-tubulin in nondiabetic rats, diabetic rats, and diabetic rats treated with hydroxyl fasudil (10 mg/kg/day). Lower panel represents quantitative analysis of the proteins in the same treatment groups. Each bar represents the mean ± SEM of 6-8 rats. *P<0.05 vs nondiabetic. NonDiab = nondiabetic; Diab = diabetic; Diab + HF = diabetic treated with hydroxyl fasudil.
Figure 3
Figure 3
Effect of diabetes and hydroxyl fasudil on P-AKT (Ser473)/AKT protein expression in the MPG. Upper panels are representative Western immunoblots of P-AKT (Ser473) and AKT in nondiabetic rats, diabetic rats, and diabetic rats treated with hydroxyl fasudil (10 mg/kg/day). Lower panel represents quantitative analysis of P-AKT/AKT in the same treatment groups. Each bar represents the mean ± SEM of 6-8 rats. *P<0.05 vs nondiabetic, #P<0.05 vs diabetic. NonDiab = nondiabetic; Diab = diabetic; Diab + HF = diabetic treated with hydroxyl fasudil.
Figure 4
Figure 4
Effect of diabetes and hydroxyl fasudil on P-PTEN (Ser380/Thr382/383)/PTEN protein expression in the MPG. Upper panels are representative Western immunoblots of P-PTEN (Ser380/Thr382/383) and PTEN in nondiabetic rats, diabetic rats, and diabetic rats treated with hydroxyl fasudil (10 mg/kg/day). Lower panel represents quantitative analysis of P-PTEN/PTEN in the same treatment groups. Each bar represents the mean ± SEM of 6-8 rats. *P<0.05 vs nondiabetic, #P<0.05 vs diabetic. NonDiab = nondiabetic; Diab = diabetic; Diab + HF = diabetic treated with hydroxyl fasudil.
See this image and copyright information in PMC

References

    1. Bacon CG, Hu FB, Giovannucci E, Glasser DB, Mittleman MA, Rimm EB. Association of type and duration of diabetes with erectile dysfunction in a large cohort of men. Diabetes Care. 2002;25:1458–1463. - PubMed
    1. Cellek S. Point of NO return for nitrergic nerves in diabetes: a new insight into diabetic complications. Curr Pharm Des. 2004;10:3683–3695. - PubMed
    1. El-Sakka AI, Lin CS, Chui RM, Dahiya R, Lue TF. Effects of diabetes on nitric oxide synthase and growth factor genes and protein expression in an animal model. Int J Impot Res. 1999;11:123–132. - PubMed
    1. Podlasek CA, Zelner DJ, Bervig TR, Gonzalez CM, McKenna KE, McVary KT. Characterization and localization of nitric oxide synthase isoforms in the BB/WOR diabetic rat. J Urol. 2001;166:746–755. - PubMed
    1. Vernet D, Cai L, Garban H, Babbitt ML, Murray FT, Rajfer J, Gonzalez-Cadavid NF. Reduction of penile nitric oxide synthase in diabetic BB/WORdp (type I) and BBZ/WORdp (type II) rats with erectile dysfunction. Endocrinology. 1995;136:5709–5717. - PubMed

Publication types

MeSH terms

Substances